Dr. Christine Moore is Global Head and Executive Director, GRACS CMC – Policy at Merck. Christine joined Merck after more than a decade in various positions at US FDA, including Acting Director of the Office of New Drug Quality Assessment and of the Office of Process and Facilities. Prior to moving into the regulatory CMC area, she spent 10 years at Pfizer and Searle/Pharmacia in API process development, process analytical technologies, scale-up, and technology transfer. Christine earned a PhD in Chemical Engineering from Massachusetts Institute of Technology and a BS in Chemical Engineering from Northwestern University.
In her current position, Christine is responsible for global outreach and advocacy to regulators and industry on regulatory topics including international harmonization and pharmaceutical manufacturing. She is a world recognized expert in regulatory approaches for advanced manufacturing technologies, including continuous manufacturing, process analytical technologies, and real time release testing.